2,4,6-Triphenylaniline
2,4,6-Triphenylaniline has anti-diabetic activity and can be encapsulated in nano-emulsions (NE) to enhance stability and permeability. The NE loaded with 2,4,6-Triphenylaniline inhibits α-glucosidase and α-amylase[1].
Product Specifications
CAS Number
[6864-20-6]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Amylases; Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/2-4-6-triphenylaniline.html
Purity
99.81
Smiles
NC1=C(C2=CC=CC=C2)C=C(C3=CC=CC=C3)C=C1C4=CC=CC=C4
Molecular Formula
C24H19N
Molecular Weight
321.42
Precautions
H315, H319, H335
References & Citations
[1]Nathiya Ranganathan, et al. 2,4,6-Triphenylaniline nanoemulsion formulation, optimization, and its application in type 2 diabetes mellitus. J Cell Physiol. 2019 Dec;234 (12) :22505-22516.
Shipping Conditions
Room Temperature
Storage Conditions
RT, protect from light
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2398-01Q-ML650 100 µL
CD44 (CD 44, CDw44, ECM III, ECMRIII, Epican, Extracellular Matrix Receptor III, GP90 Lymphocyte Homing Adhesion Receptor, HCAM, HCELL, Heparan Sulfate Proteoglycan, Hermes Antigen, HUTCH1, Hyaluronate Receptor, Indian Blood Group, Inlu Related p80 Glycoprotein, lhr, Ly 24, MC56, MDU2, MDU3, MGC10468, MIC4, MUTCH1, PGP1, Phagocytic Glycoprotein 1, Phagocytic Glycoprotein I) (MaxLight 650)
Ask
View Details 